CC
PFE icon

Cypress Capital’s Pfizer PFE Stock Holding History

Cypress Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,923
Closed -$53.8K – 276
2024
Q2 		$53.8K Buy
+1,923
New +$52.9K 0.01% 112
2023
Q4 		– Sell
-49,208
Closed -$1.63M – 79
2023
Q3 		$1.63M Buy
49,208
+1,788
+4% +$63.2K 0.48% 42
2023
Q2 		$1.74M Buy
47,420
+1,535
+3% +$59.7K 0.5% 40
2023
Q1 		$1.87M Buy
45,885
+1,728
+4% +$74.6K 0.59% 33
2022
Q4 		$2.26M Buy
44,157
+437
+1% +$21K 0.71% 28
2022
Q3 		$1.91M Buy
43,720
+1,792
+4% +$87.1K 0.67% 28
2022
Q2 		$2.2M Sell
41,928
-1,411
-3% -$71.9K 0.31% 53
2022
Q1 		$2.24M Buy
43,339
+1,902
+5% +$98.7K 0.28% 55
2021
Q4 		$2.45M Buy
41,437
+154
+0.4% +$7.63K 0.28% 53
2021
Q3 		$1.78M Buy
41,283
+4,363
+12% +$193K 0.23% 71
2021
Q2 		$1.45M Buy
36,920
+5,809
+19% +$226K 1.41% 33
2021
Q1 		$1.13M Buy
31,111
+3,577
+13% +$127K 0.46% 53
2020
Q4 		$1.01M Sell
27,534
-1,523
-5% -$55.9K 0.46% 48
2020
Q3 		$1.02M Sell
29,057
-3,102
-10% -$109K 0.47% 44
2020
Q2 		$998K Buy
+32,159
New +$1.09M 0.44% 47
2019
Q4 		$775K Buy
20,843
+1,098
+6% +$39.1K 0.33% 54
2019
Q3 		$673K Buy
19,745
+1,447
+8% +$52.6K 0.31% 53
2019
Q2 		$752K Buy
18,298
+762
+4% +$30.3K 0.34% 44
2019
Q1 		$707K Buy
17,536
+1,229
+8% +$49.2K 0.29% 45
2018
Q4 		$675K Buy
+16,307
New +$677K 0.31% 38

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Cypress Capital's PFE Position: Q3 2024 in Review

Cypress Capital sold out of Pfizer (PFE) in Q3 2024, closing a stake of 1,923 shares — an estimated $53.8K sold.

Cypress Capital first reported a position in PFE in Q4 2018 and held it in 20 quarters. The position peaked at $2.45M in Q4 2021. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Cypress Capital reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • Cypress Capital sold 1,923 Pfizer shares in Q3 2024, an estimated $53.8K.
  • Cypress Capital first reported a position in Pfizer in Q4 2018 and held it in 20 quarters.
  • Cypress Capital's Pfizer position peaked at $2.45M in Q4 2021.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Cypress Capital's 13F filing for Q3 2024, filed 12 Nov 2024.